[1]孙岩波,陈永平,李树民,等.谷氨酰胺联合益生菌对腹部大手术后病人早期肠屏障损伤及细菌易位的影响[J].肠外与肠内营养杂志,2020,(05):265-269.[doi:10.16151/j.1007-810x.2020.04.003]
　SUN Yan-bo,CHEN Yong-ping,LI Shu-min,et al.Effects of glutamine combined with probiotics on intestinal mucosal barrier and bacterial translocation after major abdominal surgery[J].PARENTERAL & ENTERAL NUTRITION,2020,(05):265-269.[doi:10.16151/j.1007-810x.2020.04.003]
点击复制

谷氨酰胺联合益生菌对腹部大手术后病人早期肠屏障损伤及细菌易位的影响
分享到：

《肠外与肠内营养》杂志[ISSN:1007-810X/CN:32-1477/R]

卷:
期数:
2020年05期
页码:
265-269
栏目:
论著
出版日期:
2020-09-10

文章信息/Info

Title:
Effects of glutamine combined with probiotics on intestinal mucosal barrier and bacterial translocation after major abdominal surgery
作者:
孙岩波 1; 2; 陈永平3; 李树民 1; 2; 等
1.昆明医科大学第二附属医院胃肠外科，云南昆明650000；2.云南省外科临床营养研究中心，云南昆明650000；3.四川省自贡市第四人民医院肝胆胰脾诊疗中心，四川自贡 643000
Author(s):
SUN Yan-bo1; 2;  CHEN Yong-ping3;  LI Shu-min1; 2;  LIN Yue-ying1; 2;  LI Wei-ming1; 2;  SUN Da-li1; 2;  XU Qing-wen1; 2;  LI Yi-jun1; 2;  CEN Yun-yun1; 2;  XU Peng-yuan1; 2
1. Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Kunming Medical University, Kunming 650000, Yunnan, China；2. Research Center for Surgical Clinical Nutrition of Yunnan Province, Kunming 650000, Yunnan, China；3.Department of Hepatobiliary Surgery, the Zigong People's Hospital, Zigong 678000, Sichuan, China
关键词:
腹部大手术 ; 肠黏膜屏障 ; 谷氨酰胺 ; 益生菌
Keywords:
Major abdominal surgery;  Intestinal mucosal barrier;  Glutamine;  Probiotics
分类号:
R459.3
DOI:
10.16151/j.1007-810x.2020.04.003
文献标志码:
A
摘要:
目的：探讨围手术期联合补充谷氨酰胺、益生菌对腹部大手术病人术后早期肠黏膜屏障和肠道细菌易位的影响。 方法：纳入2018年3月至2018年8月于昆明医科大学第二附属医院择期行腹部肝胆、胃肠外科大手术的病人60例，按随机数字表法分为对照组、观察组，每组30例。观察组较对照组在围手术期常规处理基础上给予补充谷氨酰胺和双歧杆菌乳杆菌三联活菌片。比较两组病人术前及术后12 h、24 h、48 h的血清瓜氨酸浓度和α-谷胱甘肽-S-转移酶浓度及大肠杆菌16SrDNA的拷贝数。 结果：术后两组病人血清瓜氨酸浓度与术前比较均降低，组间对比差异有统计学意义（P < 0.05）；对照组血清α-谷胱甘肽-S-转移酶浓度术后为升高趋势，观察组术后的α-谷胱甘肽-S-转移酶浓度呈波动趋势，组间比较差异有统计学意义（P < 0.05）；两组病人组内术前、术后外周血大肠杆菌16sDNA拷贝数水平变化差异均有统计学意义（P < 0.05），术后各时间点与术前比较，两组均以术后12 h外周血大肠杆菌16sDNA拷贝数水平改变最显著，但对照组和观察组两组间比较差异无统计学意义（P > 0.05）。 结论：腹部大手术病人围手术期补充谷氨酰胺和益生菌能改善病人早期肠屏障受损预警指标（血清瓜氨酸、α-谷胱甘肽-S-转移酶浓度）的变化趋势，保护肠黏膜屏障。但尚不能明确是否能抑制肠道细菌易位。
Abstract:
Objective: To explore the effects of glutamine combined with probiotics on intestinal mucosal barrier and bacteria translocation in patients with major abdominal surgery at early stage. Methods: Sixty patients who underwent elective major hepatobiliary and gastrointestinal surgery in our hospital from March 2018 to August 2018 were enrolled in this study. The patients were randomly divided into observation group (n = 30) and control group (n=30) according to the random number table method. In addition to the routine treatment, the observation group was supplemented glutamine and lactobacillus bifidus triple viable tablet during the perioperative period. The control group was only given routine treatment and nursing. Serum levels of citrulline and α-glutathione S- transferase(α-GST), copy number of blood Escherichia coli 16S rDNA in the patients were measured at preoperative and postoperative (12 h, 24 h, 48 h) period. Results: The concentrations of the serum citrate in the observation group were significantly higher than in the control group at 24 and 48 h after operations (P < 0.05). By contrast, the levels of serum α-glutathione S- transferase(α -GST) in the observation group were lower than in the control group at postoperatively 24 h and 48 h (P < 0.05). Compared to preoperative levels, the copy numbers of the peripheral blood Escherichia coli 16S rDNA in both groups were increased after operations, especially at postoperatively 12 h and 24 h (P < 0.05). The copy number of the peripheral blood Escherichia coli 16S rDNA in the observation group was lowered than in the control group after operations. However, there was no statistically significant difference between both groups (P > 0.05). Conclusion: Perioperative supplementation with combined glutamine and probiotics could alleviate the intestinal mucosal barrier injury in patients after major abdominal surgery. However, it remains to be determined whether the combined supplementation can reduce the presence of intestinal bacteria translocation.

参考文献/References:


[1] Proctor LM. The Human Microbiome Project in 2011 and Beyond. Cell Host & Microbe, 2011, 10(4):287-291.
[2] Han Y, Leng Y, Yao G. Effects of antibiotics on intestinal microflora and intestinal mucosal barrier function and its mechanisms. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2017, 29 (11):1047-1051.
[3] Piton G, Capellier G. Biomarkers of gut barrier failure in the ICU. Curr Opin Crit Care, 2016, 22(2): 152-160.
[4] Jianfeng G, Weiming Z, Ning L, et al. Serum Citrulline Is A Simple Quantitative Marker for Small Intestinal Enterocytes Mass and Absorption Function in Short Bowel Patients. J Surg Res, 2005, 127(2):177-182.
[5] Santarpia L, Catanzano F, Ruoppolo M, et al. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome. Ann Nutr Metab, 2008, 53(2):137-142.
[6] Delaney CP, O'Neill S, Manning F, et al. Plasma concentrations of glutathione S‐transferase isoenzyme are raised in patients with intestinal ischaemia. Br J Surg, 1999, 86(10):1349-1353.
[7] Block T, Nilsson TK, Bj?rck M, et al. Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest, 2008, 68(3):242-248.
[8] 黎介寿.肠内营养与肠屏障功能.肠外与肠内营养,2016,23(5):257-259.
[9] Wang B, Wu G, Zhou Z, et al. Glutamine and intestinal barrier function. Amino Acids, 2015, 47(10): 2143-2154.
[10] Achamrah N, Déchelotte P, Co?ffier M. Glutamine and the regulation of intestinal permeability: from bench to bedside. Curr Opin Clin Nutr Metab Care, 2017, 20(1): 86-91.
[11] Okumura R, Takeda K. Maintenance of intestinal homeostasis by mucosal barriers. Inflamm Regen, 2018, 38(1):5.
[12] Martens EC, Mareike N, Desai MS. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol, 2018, 16(8): 457-470.
[13] 杨 洋,陈东风.中消化道黏膜屏障的研究进展:从基础到临床.胃肠病学和肝病学杂志,2015, 24(11): 1286-1290.
[14] 于婷婷, 舒晓亮, 张勇胜, 等. 谷氨酰胺对腹部手术后病人肠黏膜通透性影响的系统评价 . 肠外与肠内营养, 2014, 21(6):324-328.
[15] Shariatpanahi ZV, Eslamian G, Ardehali SH, et al. Effects of Early Enteral Glutamine Supplementation on Intestinal Permeability in Critically Ill Patients. Indian J Crit Care Med, 2019, 23(8):356-362.
[16] Wang ZE, Wu D, Zheng LW, et al. Effects of glutamine on intestinal mucus barrier after burn injury. Am J Transl Res, 2018,10(11):3833-3846.
[17] Turroni F, Ventura M, Buttó LF, et al. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci, 2014, 71(2):183-203.
[18] Zuzana Z, Miloslav K, Klara K, et al. Lysate of Probiotic Lactobacillus casei DN-114 001 Ameliorates Colitis by Strengthening the Gut Barrier Function and Changing the Gut Microenvironment. PLoS One, 2011, 6(11):e27961.
[19] Wells JM . Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact, 2011, 10 Suppl 1(Suppl 1):S17.
[20] Judkins TC, Archer DL, Kramer DC, et al. Probiotics, Nutrition, and the Small Intestine. Curr Gastroenterol Rep, 2020, 22(1):2.
[21] Leng Y, Jiang C, Xing X, et al. Prevention of Severe Intestinal Barrier Dysfunction Through a Single-Species Probiotics Is Associated With the Activation of Microbiome-Mediated Glutamate-Glutamine Biosynthesis. Shock, 2020, Epub ahead of print.
[22] Kong C, Li S M, Yang H, et al. Screening and combining serum biomarkers to improve their diagnostic performance in the detection of intestinal barrier dysfunction in patients after major abdominal surgery. Ann Transl Med,2019, 7(16):388-398.

相似文献/References:

[1]王华伟,赵浩天,蒋小芝 综述,等.肠黏液层构成及其与相关疾病关系[J].肠外与肠内营养杂志,2019,(01):61.[doi:10.16151/j.1007-810x.2019.01.019]
　WANG Hua-wei,ZHAO Hao-tian,JIANG Xiao-zhi reviewing,et al.The composition of intestinal mucous layer and its relationship with associated diseases[J].PARENTERAL & ENTERAL NUTRITION,2019,(05):61.[doi:10.16151/j.1007-810x.2019.01.019]
[2]谈善军,孟庆洋,庄秋林,等.美托洛尔对大鼠腹腔暴露后肠黏膜屏障的影响[J].肠外与肠内营养杂志,2020,(05):261.[doi:10.16151/j.1007-810x.2020.04.002]
　TAN Shan-jun,MENG Qing-yang,ZHUANG Qiu-lin,et al.Effect of metoprolol on intestinal mucosal barrier in rats after peritoneal air exposure[J].PARENTERAL & ENTERAL NUTRITION,2020,(05):261.[doi:10.16151/j.1007-810x.2020.04.002]
[3]杨 阳,高 迪,薛沾枚,等.多糖对肠黏膜屏障影响的研究进展[J].肠外与肠内营养杂志,2021,(02):117.[doi:DOI : 10.16151/j.1007-810x.2021.02.011]
　YANG Yang,GAO Di,XUE Zhan-Mei,et al.Effect of polysaccharide on intestinal mucosal barrier function[J].PARENTERAL & ENTERAL NUTRITION,2021,(05):117.[doi:DOI : 10.16151/j.1007-810x.2021.02.011]
[4]储诚南,丁威威,杨 超,等.酚妥拉明对肠缺血再灌注损伤小鼠肠黏膜屏障及组织灌注的影响[J].肠外与肠内营养杂志,2023,(01):38.[doi:DOI : 10.16151/j.1007-810x.2023.01.010]
　CHU Cheng-nan,DING Wei-wei,YANG Chao,et al.Effect of phentolamine on gut barrier and perfusion in mice afterintestinal ischemia-reperfusion injury[J].PARENTERAL & ENTERAL NUTRITION,2023,(05):38.[doi:DOI : 10.16151/j.1007-810x.2023.01.010]

备注/Memo

备注/Memo:
基金项目 ：云南省外科临床营养研究中心基金项目（2017NS302,2018NS0317,2018NS0318）；云南省基础研究计划[昆医联合专项2019FE001（-223），2019FE001（-167）；云南省卫生健康委员会医学后备人才培养计划（H-2018067） 作者简介 ：孙岩波，主治医师，医学硕士，从事普通外科和临床营养的临床及科研工作。E-mail：syb0311@163.com 共同第一作者 ：陈永平，住院医师，医学硕士，从事临床营养支持和普通外科工作。E-mail：573015573@qq.com 通讯作者 ：徐鹏远，E-mail：pyxu778@sina.com 通讯作者 ：岑云云，E-mail：glwk0981@163.com
更新日期/Last Update: 1900-01-01